<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-vaccines-07-00070">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gerna</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sarasini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Patrone</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Percivalle</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Fiorina</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Campanini</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gallina</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Baldanti</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Revello</surname>
    <given-names>M.G.</given-names>
   </name>
  </person-group>
  <article-title>Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection</article-title>
  <source>J. Gen. Virol.</source>
  <year>2008</year>
  <volume>89</volume>
  <fpage>853</fpage>
  <lpage>865</lpage>
  <pub-id pub-id-type="doi">10.1099/vir.0.83523-0</pub-id>
  <pub-id pub-id-type="pmid">18343825</pub-id>
 </element-citation>
</ref>
